FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2081887629> ?p ?o ?g. }

• W2081887629 endingPage "630" @default.
• W2081887629 startingPage "622" @default.
• W2081887629 abstract "In Brief Objective: To compare bone mineral density (BMD) and bone turnover changes after therapy withdrawal in postmenopausal women treated with alendronate or estrogen-progestin. Design: In this randomized, blinded, multinational, placebo-controlled trial, 1,609 healthy postmenopausal women ages 45 to 59 years were assigned to receive alendronate, placebo, or open-label estrogen-progestin (conjugated equine estrogens plus medroxyprogesterone acetate or a cyclic regimen of 17β-estradiol, norethisterone acetate and estradiol). Of the original women, one third after year 2 and one third after year 4 were switched from alendronate to placebo, while remaining blinded to treatment assignment. The women taking estrogen-progestin in years 1 to 4 were followed off therapy in years 5 and 6. BMD at the lumbar spine and hip and biochemical markers of bone turnover were measured. Results: The treatment groups described in the current report represent 860 women at baseline; 481 women entered year 5, and 430 completed 6 years. BMD steadily decreased in the placebo group during all 6 years. In contrast, spine and hip BMD increased during the first 4 years in the groups receiving daily continuous alendronate 5 mg and estrogen-progestin. During years 5 and 6, BMD decreased at the lumbar spine -2.42% (95% CI = −4.10, −0.74) and total hip −1.09% (−2.60, 0.41) in the group previously treated with alendronate 5 mg for 4 years. In comparison, large BMD decreases were observed at the spine [−7.69% (−8.96, −6.41)] and total hip [−5.16% (−6.30, −4.01)] among women who had received estrogen-progestin for 4 years. Conclusion: Alendronate produces greater residual skeletal effects than estrogen-progestin after therapy discontinuation. Early postmenopausal women (N = 860) were randomized to placebo, alendronate, or estrogen-progestin for 4 years followed by 2 years on placebo, with 430 women completing all 6 years of the trial in these treatment subgroups. Bone density increased during the first 4 years of treatment with alendronate or estrogen-progestin, but decreases in bone density and increases in bone turnover during the subsequent 2 years were much larger after stopping estrogen-progestin than after stopping alendronate." @default.
• W2081887629 created "2016-06-24" @default.
• W2081887629 creator A5005612011 @default.
• W2081887629 creator A5008975841 @default.
• W2081887629 creator A5027284062 @default.
• W2081887629 creator A5036573328 @default.
• W2081887629 creator A5040802687 @default.
• W2081887629 creator A5043349829 @default.
• W2081887629 creator A5046421559 @default.
• W2081887629 creator A5048725197 @default.
• W2081887629 creator A5052103282 @default.
• W2081887629 creator A5055301286 @default.
• W2081887629 creator A5066893376 @default.
• W2081887629 creator A5073558782 @default.
• W2081887629 date "2004-11-01" @default.
• W2081887629 modified "2023-10-10" @default.
• W2081887629 title "Changes in bone density and turnover after alendronate or estrogen withdrawal" @default.
• W2081887629 cites W1561293749 @default.
• W2081887629 cites W1593442063 @default.
• W2081887629 cites W1970107478 @default.
• W2081887629 cites W1971915328 @default.
• W2081887629 cites W1986238913 @default.
• W2081887629 cites W1987169166 @default.
• W2081887629 cites W1989783674 @default.
• W2081887629 cites W1993932749 @default.
• W2081887629 cites W1995055473 @default.
• W2081887629 cites W2008147692 @default.
• W2081887629 cites W2025103357 @default.
• W2081887629 cites W2027671535 @default.
• W2081887629 cites W2035593552 @default.
• W2081887629 cites W2039839937 @default.
• W2081887629 cites W2039860789 @default.
• W2081887629 cites W2046351152 @default.
• W2081887629 cites W2046983302 @default.
• W2081887629 cites W2049146115 @default.
• W2081887629 cites W2054217658 @default.
• W2081887629 cites W2057332307 @default.
• W2081887629 cites W2059244869 @default.
• W2081887629 cites W2073420242 @default.
• W2081887629 cites W2078629144 @default.
• W2081887629 cites W2084408138 @default.
• W2081887629 cites W2089976549 @default.
• W2081887629 cites W2090982932 @default.
• W2081887629 cites W2096944331 @default.
• W2081887629 cites W2097506722 @default.
• W2081887629 cites W2101593668 @default.
• W2081887629 cites W2104949625 @default.
• W2081887629 cites W2126070576 @default.
• W2081887629 cites W2151649765 @default.
• W2081887629 cites W2152063648 @default.
• W2081887629 cites W2153005915 @default.
• W2081887629 cites W2153009489 @default.
• W2081887629 cites W2160032820 @default.
• W2081887629 cites W2162255898 @default.
• W2081887629 cites W2321227665 @default.
• W2081887629 cites W2340685677 @default.
• W2081887629 cites W2460598555 @default.
• W2081887629 cites W95785129 @default.
• W2081887629 doi "https://doi.org/10.1097/01.gme.0000123641.76105.b5" @default.
• W2081887629 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15545790" @default.
• W2081887629 hasPublicationYear "2004" @default.
• W2081887629 type Work @default.
• W2081887629 sameAs 2081887629 @default.
• W2081887629 citedByCount "108" @default.
• W2081887629 countsByYear W20818876292012 @default.
• W2081887629 countsByYear W20818876292013 @default.
• W2081887629 countsByYear W20818876292014 @default.
• W2081887629 countsByYear W20818876292015 @default.
• W2081887629 countsByYear W20818876292016 @default.
• W2081887629 countsByYear W20818876292017 @default.
• W2081887629 countsByYear W20818876292018 @default.
• W2081887629 countsByYear W20818876292019 @default.
• W2081887629 countsByYear W20818876292020 @default.
• W2081887629 countsByYear W20818876292021 @default.
• W2081887629 countsByYear W20818876292022 @default.
• W2081887629 countsByYear W20818876292023 @default.
• W2081887629 crossrefType "journal-article" @default.
• W2081887629 hasAuthorship W2081887629A5005612011 @default.
• W2081887629 hasAuthorship W2081887629A5008975841 @default.
• W2081887629 hasAuthorship W2081887629A5027284062 @default.
• W2081887629 hasAuthorship W2081887629A5036573328 @default.
• W2081887629 hasAuthorship W2081887629A5040802687 @default.
• W2081887629 hasAuthorship W2081887629A5043349829 @default.
• W2081887629 hasAuthorship W2081887629A5046421559 @default.
• W2081887629 hasAuthorship W2081887629A5048725197 @default.
• W2081887629 hasAuthorship W2081887629A5052103282 @default.
• W2081887629 hasAuthorship W2081887629A5055301286 @default.
• W2081887629 hasAuthorship W2081887629A5066893376 @default.
• W2081887629 hasAuthorship W2081887629A5073558782 @default.
• W2081887629 hasConcept C126322002 @default.
• W2081887629 hasConcept C126894567 @default.
• W2081887629 hasConcept C142724271 @default.
• W2081887629 hasConcept C170033053 @default.
• W2081887629 hasConcept C204787440 @default.
• W2081887629 hasConcept C27081682 @default.
• W2081887629 hasConcept C2776306185 @default.
• W2081887629 hasConcept C2776541429 @default.
• W2081887629 hasConcept C2776607906 @default.

• next